In January, the Accreditation Council for Graduate Medical Education withdrew accreditation for the program “under special circumstances,” but did not provide details on the reasons.
“We strongly disagree with the ACGME’s decision,” Crozer CEO Anthony Esposito said in a statement shared with Becker’s. “We have worked with the remaining residents to secure training sites for them.”
The ACGME’s review committee can withdraw a sponsoring institution or program’s accreditation in the event of “a catastrophic loss of resources, including faculty members, facilities, or funding” or “egregious non-compliance with accreditation requirements,” according to its policies and procedures list.
Los Angeles-based Prospect Medical Holdings, the for-profit owner of Crozer, sued the ACGME in January, alleging that resident physicians left the training program at Crozer-Chester Medical Center due to concerns that their efforts between January and June may not be credited toward educational prerequisites.
An anonymous complaint that surgical volumes were insufficient for residents’ training needs launched the ACGME investigation, according to the Inquirer. The program had 15 slots, but only three residents remained when Crozer lost its appeal.
“We are actively recruiting clinicians to our facilities to help ensure that our patients continue to receive safe, quality care and we do not anticipate any interruption to our services as a result of the ACGME’s decision,” Mr. Esposito said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
